Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling-Reference-Cited by-同舟云学术

Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling

Published:2015-06-11 Issue:1 Volume:6 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Zuckermann Marc,Hovestadt Volker,Knobbe-Thomsen Christiane B.,Zapatka Marc,Northcott Paul A.,Schramm Kathrin,Belic Jelena,Jones David T. W.,Tschida Barbara,Moriarity Branden,Largaespada David,Roussel Martine F.,Korshunov Andrey,Reifenberger Guido,Pfister Stefan M.,Lichter Peter,Kawauchi Daisuke,Gronych Jan

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms8391.pdf

Reference48 articles.

1. Garraway, L. A. & Lander, E. S. Lessons from the cancer genome. Cell 153, 17–37 (2013).

2. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

3. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

4. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816–821 (2012).

5. Valerie, K. & Povirk, L. F. Regulation and mechanisms of mammalian double-strand break repair. Oncogene 22, 5792–5812 (2003).

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Clinical Models for CAR T-Cell Therapy for Glioma;Cells;2024-09-04

2. Applications of CRISPR/Cas9 technology in mice and livestock genome editing: Current research;Annals of Animal Science;2024-08-29

3. A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma;Cell Reports;2024-08

4. A Review: CRISPR Cas System and the Mechanism With an Inhibition of Binding of CRISPR Cas‐9;Nano Select;2024-07-18

5. Exploring Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-Associated Protein 9 (CRISPR-Cas9) as a Therapeutic Modality for Cancer: A Scoping Review;Cureus;2024-07-11